Inside Precision Medicine June 17, 2024
IPM staff

With better methods needed for matching patients with depression with appropriate treatments, researchers at Stanford University, reporting today in Nature Medicine, say they have identified six biological subtypes (biotypes) of depression. The team also identified existing treatments that could be more likely, or less likely, to be effective against three of those biotypes.

According to statistics from the National Institute of Mental Health’s 2021 National Survey on Drug Use and Health, roughly 21 million people (8.3% of the population) in the United States suffer from major depression. The rates are significantly higher for women (10.3%) than for males (6.2%). Major depression is defined as a period of at least two weeks when a person experienced a depressed mood or loss...

Today's Sponsors


Today's Sponsor


Topics: AI (Artificial Intelligence), Mental Health, Provider, Radiology, Survey / Study, Technology, Trends
Apps and Wearables Bridge Gaps in Mental Health Care
Private Equity in Behavioral Health: Exploring Current Investment Activity
What Intermountain Health Hopes to Achieve with its New Behavioral Health Partnership
Study: Medical debt linked to mental health care delays among adults with depression and anxiety
‘Legal’ psychedelic mushrooms actually contain illegal hallucinogens, study shows

Share This Article